Early Access — free while we kick the tires
EdgarHawk

AVERY MORE

Director

Director
2 filings analyzed · 1 company · Latest 2025-03-06

Companies

Company Buys Sells Direction
SOLAREDGE TECHNOLOGIES, INC. SEDG 2 0 Net buying

Activity

March 2025
high
Buy
30,000 shares
$411,000
Significance 6/10

Director AVERY MORE buys 30,000 SEDG shares at $13.70; stock now $16.02 (+17% since trade). Company lost $1.2B in latest fiscal year.

AVERY MORE (Director) purchased 30,000 shares at $13.70 on 2025-03-04, bringing total holdings to 274,478 shares — a +12.3% increase in position size. The purchase price of $13.70 is 78.8% below the 52-week high of $75.72, reflecting a stock trading near its annual lows despite recent momentum (+15.3% in 30 days, +25.4% in 90 days). At SEDG specifically, the insider has a strong track record with 3 of 4 prior buys showing positive 90-day returns, and this most recent buy follows that pattern: the stock has already appreciated to $16.02 post-trade, consistent with his historical timing success at this ticker. However, the company's fundamentals are severely distressed—annual revenue declined 69.7% year-over-year to $260.9M and net income was negative $1.2B in the latest fiscal year—raising questions about the basis for conviction in a sharply unprofitable business trading at a $941.7M market cap.

November 2024
high
Buy
156,000 shares
$2,129,400
Significance 6/10

Director AVERY MORE bought 156,000 shares of SEDG at $13.65 on 2024-11-11 (+176.3% holdings increase); stock now at $12.10, down 88.2% from 52-week high.

AVERY MORE, a Director, made a substantial open-market purchase of 156,000 shares at $13.65 on 2024-11-11, increasing his holdings from 88,478 shares to 244,478 shares (a 176.3% increase in stake size). The timing context is mixed: while his prior trade at this ticker on 2024-02-29 showed a -28.3% 90-day return, two other SEDG buys (2023-11-09) each delivered positive 90-day returns of +7.4% and +6.6%, indicating 66.67% accuracy in same-ticker buying decisions historically. However, the current price ($12.10) reflects severe deterioration, down 88.2% from the 52-week high of $102.24 and down 35.7% over the past 30 days alone, suggesting the purchase price of $13.65 may already be underwater relative to where the stock has moved post-transaction. The company reported a $-1.2B net loss in the latest quarter, annual revenue contracted 4.3%, and the P/E of 19.84 is elevated for a company in loss-making status, indicating significant operational headwinds that appear unresolved.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access